INTRODUCTION
============

Imiquimod 5% cream is currently approved for topical treatment of genital warts, superficial basal cell carcinoma and actinic keratoses. So far, several cases of vitiligo-like imiquimod-induced depigmentation have been reported.^[@r01],[@r02]^ The present case report refers to the observation of vulvar depigmentation and onset of multiple halos of hypomelanosis around several melanocytic nevi of the trunk following treatment with imiquimod 5% cream for vulvar condylomata ([Figures 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}).^[@r02]^

![Multiple halos of depigmentation at site of Imiquimod application](abd-89-05-0806-g01){#f01}

![Several halos nevi (Sutton\'s nevi) of the trunk](abd-89-05-0806-g02){#f02}

CASE REPORT
===========

A 25-year-old Caucasian female with genital warts was treated with imiquimod 5% cream three times weekly for 12 weeks .The treatment was well tolerated .At 4-month follow-up after discontinuation, the patient was noted to have some residual condylomata and marked depigmentation at the site of application.

At 8-month follow-up she was noted do have developed halos of hypomelanosis around four pre-existing nevi of the trunk . At 18 months follow-up the genital depigmentation persisted and the halo nevi of the trunk were still present. Personal and family history for melanoma, vitiligo and thyroid disorders were negative .Laboratory investigations, including a panel of auto-antibodies, were performed without any significant abnormal finding.

DISCUSSION
==========

The case presented here was characterized by the co-existence of genital vitiligo-like depigmentation and appearance of several halo nevi of the trunk. ([Figures 3](#f03){ref-type="fig"} and [4](#f04){ref-type="fig"}).^[@r03],[@r04],[@r05]^

![Halo nevo in the left deltoid region](abd-89-05-0806-g03){#f03}
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Different mechanisms of imiquimod-induced depigmentation have been reported including postinflammatory depigmentation, necrosis of melanocytes and immune mediated vitiligo-like reactions.^[@r06],[@r07]^

As vitiligo may be expression of a cytotoxic T lymphocyte immune reaction, it may be conceivable that imiquimod could contribute to the elimination of melanocytes by inducing acquired immunity through the induction of cytokines.^[@r01],[@r06],[@r07]^

If this is true, it is likely that both vitiligo-like depigmentation at the site of application and halo of hypomelanosis around melanocytic nevi of the trunk have been induced by the same immunologic mechanism evoked by topical application of imiquimod.^[@r01],[@r06],[@r07]^
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